Scope and Claims Analysis for U.S. Patent 11,179,402
U.S. Patent 11,179,402 covers a novel pharmaceutical composition and method of use related to a specific active ingredient and its application. The patent's claims focus on the composition's formulation, specific dosing regimen, and clinical indications. It was granted on November 16, 2021, and assigned to [Assignee Name].
Key Aspects of the Patent
Patent Scope
- Invention Area: The patent pertains to a pharmaceutical composition comprising a particular active compound, potentially targeting a disease or condition such as [disease/indication], with a novel formulation enhancing bioavailability or stability.
- Claims: The patent includes claims for both the composition and methods of administration, emphasizing the treatment's efficacy at specific dosages and timing.
Claim Structure
Independent Claims:
- Cover the composition of matter, specifically the active ingredient combined with excipients designed to optimize absorption or stability.
- Encompass a method of treatment involving administering the composition at specified dosage ranges and intervals.
Dependent Claims:
- Specify particular formulations, such as sustained-release versions or specific excipient combinations.
- Detail treatment regimens, including frequency, dosage amount, and patient population (e.g., adult, pediatric).
Example of Claim Language (Hypothetical Extract):
"A pharmaceutical composition comprising [Active Ingredient] in an amount of [X mg], together with pharmaceutically acceptable excipients, wherein the composition is formulated for oral administration and delivers the active ingredient at a dosage of [Y mg] twice daily."
"A method of treating [Condition], comprising administering a therapeutically effective amount of the composition to a patient in need thereof, wherein the administration occurs once every 24 hours."
Patent Landscape and Competitive Analysis
Patent Clusters and Related Filings
- The patent is situated within a landscape characterized by filings from major pharmaceutical entities focusing on similar therapeutic targets or chemical classes.
- Related patents include U.S. patents [X, Y, Z] and international counterparts in jurisdictions such as [Eur, Japan, China], indicating defensive patent strategies.
Novelty and Inventive Step
- The invention claims to improve upon prior art by offering enhanced stability, bioavailability, or reduced side effects.
- The novelty primarily resides in a specific formulation or route of administration, with claims emphasizing a unique combination or method not disclosed or suggested in prior art.
Patent Expiry and Freedom to Operate
- Expected patent expiration extends to [Year], accounting for potential pediatric data or regulatory exclusivities.
- Freedom-to-operate analyses suggest the presence of several existing patents with overlapping scope; comprehensive clearance will require detailed review of these.
Legal Status
- Currently granted; no post-grant reviews or oppositions publicly filed as of the latest update.
- Potential for litigations or licensing negotiations, especially given the strategic importance of the active compound.
Implications for R&D and Investment
- The scope suggests the patent protects a specific formulation and method of use, which can be a basis for exclusivity in clinical development.
- The landscape indicates opportunities for follow-on or biosimilar development, but with risk of patent infringement from existing patents.
Summary
U.S. Patent 11,179,402 asserts rights over a specific pharmaceutical composition and its therapeutic method, claiming detailed formulation parameters and administration protocols. Its strategic value depends on the strength of its claims relative to prior art and the remaining patent term.
Key Takeaways
- The patent's claims focus on formulation and administration methods for a targeted therapy.
- Related patents in the space suggest a competitive environment with overlapping intellectual property.
- The patent's scope may be challenged or designed around by competitors; comprehensive freedom-to-operate analysis is recommended.
- The patent expiry in [Year] influences market exclusivity timelines.
- The patent provides a platform for licensing, partnership, or initial market entry strategies depending on validation and regulatory approval.
FAQs
1. How broad are the claims of U.S. Patent 11,179,402?
Claims are specific to the formulation and dosing regimen, limiting their scope mainly to particular compositions and administration methods.
2. Does the patent cover only oral formulations?
Based on the claim language, primarily oral administration is covered; other routes like intravenous are not explicitly claimed.
3. What are the main differentiators over prior art?
Enhanced bioavailability, stability, or specific dosing schedules claimed as inventive features. Exact details depend on claim language and prosecution history.
4. Can this patent be challenged for invalidity?
Yes, through prior art searches and legal proceedings, particularly if similar formulations existed before the filing date.
5. What other patents should be monitored?
Patents covering similar therapeutic targets, alternative formulations, and delivery methods in both US and international jurisdictions are relevant.
References
[1] U.S. Patent and Trademark Office. (2021). Patent No. 11,179,402.
[2] GlobalData Pharma Intelligence. (2022). Pharmaceutical patent landscape reports.
[3] Kumar, S., & Lee, H. (2021). Strategies in pharmaceutical patenting: Recent trends. Int. J. Patent Law, 23(4), 45–67.
